Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1425943000;43001;43002 chr2:178633584;178633583;178633582chr2:179498311;179498310;179498309
N2AB1261838077;38078;38079 chr2:178633584;178633583;178633582chr2:179498311;179498310;179498309
N2A1169135296;35297;35298 chr2:178633584;178633583;178633582chr2:179498311;179498310;179498309
N2B519415805;15806;15807 chr2:178633584;178633583;178633582chr2:179498311;179498310;179498309
Novex-1531916180;16181;16182 chr2:178633584;178633583;178633582chr2:179498311;179498310;179498309
Novex-2538616381;16382;16383 chr2:178633584;178633583;178633582chr2:179498311;179498310;179498309
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: P
  • RefSeq wild type transcript codon: CCA
  • RefSeq wild type template codon: GGT
  • Domain: Ig-93
  • Domain position: 29
  • Structural Position: 45
  • Q(SASA): 0.6453
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
P/S rs1466149919 -0.345 0.999 N 0.633 0.375 0.366659145958 gnomAD-2.1.1 4.03E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.92E-06 0
P/S rs1466149919 -0.345 0.999 N 0.633 0.375 0.366659145958 gnomAD-4.0.0 1.59234E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85969E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
P/A 0.0752 likely_benign 0.0818 benign -0.402 Destabilizing 0.998 D 0.599 neutral D 0.580613419 None None N
P/C 0.6343 likely_pathogenic 0.6959 pathogenic -0.79 Destabilizing 1.0 D 0.748 deleterious None None None None N
P/D 0.2836 likely_benign 0.3286 benign -0.357 Destabilizing 0.504 D 0.295 neutral None None None None N
P/E 0.235 likely_benign 0.2743 benign -0.46 Destabilizing 0.994 D 0.585 neutral None None None None N
P/F 0.5488 ambiguous 0.5664 pathogenic -0.637 Destabilizing 1.0 D 0.747 deleterious None None None None N
P/G 0.3368 likely_benign 0.3961 ambiguous -0.506 Destabilizing 0.998 D 0.605 neutral None None None None N
P/H 0.2222 likely_benign 0.2704 benign -0.028 Destabilizing 1.0 D 0.719 prob.delet. None None None None N
P/I 0.3462 ambiguous 0.3502 ambiguous -0.269 Destabilizing 1.0 D 0.761 deleterious None None None None N
P/K 0.2918 likely_benign 0.3644 ambiguous -0.465 Destabilizing 1.0 D 0.647 neutral None None None None N
P/L 0.1392 likely_benign 0.1419 benign -0.269 Destabilizing 1.0 D 0.754 deleterious D 0.582296109 None None N
P/M 0.3504 ambiguous 0.374 ambiguous -0.531 Destabilizing 1.0 D 0.722 prob.delet. None None None None N
P/N 0.278 likely_benign 0.323 benign -0.309 Destabilizing 0.999 D 0.723 prob.delet. None None None None N
P/Q 0.171 likely_benign 0.2067 benign -0.508 Destabilizing 0.999 D 0.711 prob.delet. N 0.502029597 None None N
P/R 0.2313 likely_benign 0.2892 benign 0.014 Stabilizing 0.999 D 0.747 deleterious D 0.538300296 None None N
P/S 0.1189 likely_benign 0.1319 benign -0.63 Destabilizing 0.999 D 0.633 neutral N 0.500849189 None None N
P/T 0.1058 likely_benign 0.1147 benign -0.633 Destabilizing 0.999 D 0.655 neutral N 0.502312152 None None N
P/V 0.2418 likely_benign 0.2621 benign -0.282 Destabilizing 1.0 D 0.728 prob.delet. None None None None N
P/W 0.7592 likely_pathogenic 0.7961 pathogenic -0.715 Destabilizing 1.0 D 0.74 deleterious None None None None N
P/Y 0.5234 ambiguous 0.5681 pathogenic -0.432 Destabilizing 1.0 D 0.744 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.